Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schacker

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Herpes : the Journal of the IHMF|February 28, 2002
The role of HSV in the transmission and progression of HIVT Schacker
Postgraduate Medicine|October 23, 1997
Primary HIV infection. Early diagnosis and treatment are critical to outcomeT Schacker
STEP Perspective|April 1, 1996
Primary HIV infectionT Schacker
STEP Perspective|January 1, 1997
HSV-2 and HIV: consequences of an endemic opportunistic infectionA Wald, T Schacker, L Corey
Journal of Medical Virology|January 1, 1996
Lack of detection of HSV DNA in PBMCs and lymph nodes of HIV-infected personsL Corey, A Hobson, T Schacker
Antimicrobial Agents and Chemotherapy|May 1, 1993
Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovirS Safrin, T Schacker, J Delehanty, et al.
Journal of Medical Virology|January 1, 1993
Potential for combined therapy with 348U87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infectionS Safrin, T Schacker, J Delehanty, et al.
Annals of Internal Medicine|August 15, 1996
Clinical and epidemiologic features of primary HIV infectionT Schacker, A C Collier, J Hughes, et al.
The Journal of Infectious Diseases|November 17, 1998
Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected menT Schacker, J Zeh, H L Hu, et al.
Journal of Virology|September 1, 1997
The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissueQ Li, K Gebhard, T Schacker, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Herpes : the Journal of the IHMF|February 28, 2002
The role of HSV in the transmission and progression of HIVT Schacker
Postgraduate Medicine|October 23, 1997
Primary HIV infection. Early diagnosis and treatment are critical to outcomeT Schacker
STEP Perspective|April 1, 1996
Primary HIV infectionT Schacker
STEP Perspective|January 1, 1997
HSV-2 and HIV: consequences of an endemic opportunistic infectionA Wald, T Schacker, L Corey
Journal of Medical Virology|January 1, 1996
Lack of detection of HSV DNA in PBMCs and lymph nodes of HIV-infected personsL Corey, A Hobson, T Schacker
Antimicrobial Agents and Chemotherapy|May 1, 1993
Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovirS Safrin, T Schacker, J Delehanty, et al.
Journal of Medical Virology|January 1, 1993
Potential for combined therapy with 348U87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infectionS Safrin, T Schacker, J Delehanty, et al.
Annals of Internal Medicine|August 15, 1996
Clinical and epidemiologic features of primary HIV infectionT Schacker, A C Collier, J Hughes, et al.
The Journal of Infectious Diseases|November 17, 1998
Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected menT Schacker, J Zeh, H L Hu, et al.
Journal of Virology|September 1, 1997
The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissueQ Li, K Gebhard, T Schacker, et al.
Pageof 3